Skip to content
Search

Latest Stories

Bristol Myers Squibb becomes UK's first pharma company to be accredited as 'menopause friendly'

Pharmaceutical giant Bristol Myers Squibb has become the first pharmaceutical company in the UK to be accredited as a 'menopause friendly workplace'.

The accreditation, awarded by an independent panel of judges, recognises employers who put diversity, inclusion and wellbeing at the centre stage of their business.


Bristol Myers Squibb (BMS) said it rung in the changes in recognition of the fact that nearly eight of 10 menopausal women are in work and that this is the fastest growing demographic in the workforce.

Panel members described BMS UK&I’s application as “outstanding” and acknowledged "the huge strides they have made to help normalise the menopause" by fostering an inclusive culture.

Support and education

The company said it has pioneered a range of menopause-friendly initiatives to support women at work since last March which include:

• A detailed internal menopause guidance document to support and educate all UK&I staff

o This includes details on the different types of menopause, how symptoms can affect daily work, and signposting to internal and external resources

• A reasonable adjustments form to help accommodate staff experiencing menopausal symptoms

• A Rapid Access Female Treatment Service (RAFT) that allows employees experiencing severe menopausal symptoms in the workplace to be referred to a consultant gynaecologist who is an accredited British Menopause Society specialist

• Training 17 menopause advocates across UK&I sites who help educate, raise awareness, and signpost colleagues on their menopause journey

• A menopause portal developed for employees, by employees, to access support and information

• Training more than 60 per cent of the UK&I workforce on menopause awareness

Scott Cooke, general manager for BMS UK&I, said: “I am so proud that Bristol Myers Squibb UK&I is the first pharmaceutical company to have been officially awarded Menopause Friendly status, highlighting our continued commitment to ensuring that all people affected by the menopause feel supported at work.

"I am delighted that we are helping lead the way in changing how businesses think about the menopause, and we remain passionate about accelerating change in workplace best practice and fostering an inclusive culture where everyone can bring their authentic selves to work every day.”

Members of the accreditation board include Professor Jo Brewis, lead author of the Government Equalities Office report on ‘The effects of menopause transition on women’s economic participation in the UK’, and Bernice Allport MBE, former chair of the cross-government Menopause Network.

More For You

MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less